Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: The Eurgast-EPIC project

  • C. A. González
  • , F. Megraud
  • , A. Buissonniere
  • , L. Lujan Barroso
  • , A. Agudo
  • , E. J. Duell
  • , M. C. Boutron-Ruault
  • , F. Clavel-Chapelon
  • , D. Palli
  • , V. Krogh
  • , A. Mattiello
  • , R. Tumino
  • , C. Sacerdote
  • , J. R. Quirós
  • , E. Sanchez-Cantalejo
  • , C. Navarro
  • , A. Barricarte
  • , M. Dorronsoro
  • , K. T. Khaw
  • , N. Wareham
  • N. E. Allen, K. K. Tsilidis, H. Bas Bueno-de-Mesquita, S. M. Jeurnink, M. E. Numans, P. H.M. Peeters, P. Lagiou, E. Valanou, A. Trichopoulou, R. Kaaks, A. Lukanova-McGregor, M. M. Bergman, H. Boeing, J. Manjer, B. Lindkvist, R. Stenling, G. Hallmans, L. M. Mortensen, K. Overvad, A. Olsen, A. Tjonneland, K. Bakken, V. Dumeaux, E. Lund, M. Jenab, I. Romieu, D. Michaud, T. Mouw, F. Carneiro, C. Fenge, E. Riboli

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: The Eurgast-EPIC project'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases